New treatment strategy in multiple sclerosis: High dose immunosuppressive therapy with autologous stem cell transplantation

被引:0
|
作者
Novik, A. [1 ]
Kuznetsov, A. [2 ]
Afanasiev, B. [3 ]
Lisukov, I. [4 ]
Rykavicin, O. [5 ]
Myasnikov, A.
Ionova, T. [6 ,7 ]
Melnichenko, V. [1 ]
Fedorenko, D. [1 ]
Kishtovich, A. [7 ]
Gorodokin, G.
机构
[1] Pirogov Natl Med Surg Ctr, Dept Haematol & Cellular Therapy, Moscow, Russia
[2] Pirogov Natl Med Surg Ctr, Dept Neurol, Moscow, Russia
[3] Pavlov State Med Univ, Dept Bone Marrow Transplant, St Petersburg, Russia
[4] Russian Acad Sci, Siberian Branch, Inst Clin Immunol, Dept Haematol, Novosibirsk, Russia
[5] Burdenko Cent Mil Hosp, Dept Haematol, Moscow, Russia
[6] Republ Hosp, Dept Haematol, Petrozavodsk, Russia
[7] Multinatl Ctr Qual Life Res, Unit Qol, St Petersburg, Russia
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
19
引用
收藏
页码:195 / 195
页数:1
相关论文
共 50 条
  • [2] High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis
    Shevchenko, Yury L.
    Novik, Andrei A.
    Kuznetsov, Aleksey N.
    Afanasiev, Boris V.
    Lisukov, Igor A.
    Kozlov, Vladimir A.
    Rykavicin, Oleg A.
    Ionova, Tatyana I.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Kulagin, Alexander D.
    Shamanski, Sergei V.
    Ivanov, Roman A.
    Gorodokin, Gary
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (08) : 922 - 928
  • [3] Immunosuppressive therapy (IT) with autologous hematopoietic stem cell transplantation (AHSCT) as a new treatment strategy in multiple sclerosis (MS)
    Shevchenko, Y. L.
    Novik, W. W.
    Kuznetsov, W. N.
    Afanasyev, B. V.
    Lisukov, I. A.
    Rykavicin, O. A.
    Ionova, T. I.
    Melnichenko, V. Y.
    Fedorenko, D. A.
    Kishtovich, A. V.
    Kruglina, R. V.
    Kondrashov, A. V.
    Ivanov, R. A.
    Gorodokin, G. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 27 - 27
  • [4] Treatment outcomes in multiple sclerosis patients after high dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation
    Shevchenko, Y.
    Novik, A.
    Kuznetsov, A.
    Afanasyev, B.
    Lisukov, I.
    Rykavicin, O.
    Myasnikov, A.
    Ionova, T.
    Melnichenko, V.
    Fedorenko, D.
    Kishtovich, A.
    Kruglina, R.
    Kartashov, A.
    Ivanov, R.
    Gorodokin, G.
    JOURNAL OF NEUROLOGY, 2008, 255 : 181 - 181
  • [5] Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).
    Nash, RA
    Kraft, GH
    Bowen, JD
    McSweeney, PA
    Pavletic, S
    Al-Omaishi, J
    Corboy, JR
    Holmberg, LA
    Openshaw, H
    Prather, K
    Ryan, K
    Storek, J
    Zunt, JR
    Sullivan, KM
    BLOOD, 2000, 96 (11) : 842A - 843A
  • [6] Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT).
    Nash, RA
    Bowen, JD
    McSweeney, PA
    Sullivan, KM
    Pavletic, ZS
    Maravilla, KR
    Al-Omaishi, J
    Corboy, JR
    Derrington, D
    DiPersio, J
    Georges, GE
    Holmberg, LA
    LeMaistre, CF
    Openshaw, H
    Ryan, K
    Sunderhaus, J
    Storek, J
    Zunt, J
    Kraft, GH
    BLOOD, 2001, 98 (11) : 687A - 687A
  • [7] New perspectives on the use of autologous haematopoietic stem cell transplantation in multiple sclerosis: three strategies of high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation
    Shevchenko, Y.
    Novik, A.
    Kuznetsov, A.
    Melnichenko, V.
    Fedorenko, D.
    Ionova, T.
    Kruglina, R.
    Kurbatova, K.
    Kartashov, A.
    Gorodokin, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S26 - S26
  • [8] High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
    Nash, RA
    Bowen, JD
    McSweeney, PA
    Pavletic, SZ
    Maravilla, KR
    Park, MS
    Storek, J
    Sullivan, KM
    Al-Omaishi, J
    Corboy, JR
    DiPersio, J
    Georges, GE
    Gooley, TA
    Holmberg, LA
    LeMaistre, CF
    Ryan, K
    Openshaw, H
    Sunderhaus, J
    Storb, R
    Zunt, J
    Kraft, GH
    BLOOD, 2003, 102 (07) : 2364 - 2372
  • [9] Immunosuppressive therapy (IT) with autologous hematopoietic stem cell transplantation (AHSCT) as a new treatment modality in multiple sclerosis (MS)
    Novik, A. A.
    Afanasyev, B. V.
    Lisukov, I. A.
    Rykavicin, O. A.
    Ionova, T. I.
    Melnichenko, V. Y.
    Fedorenko, D. A.
    Kishtovich, A. V.
    Kruglina, R. V.
    Gorodokin, G. J.
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S32 - S33
  • [10] Immunosuppressive therapy (IT) with autologous hematopoietic stem cell transplantation (AHSCT) as a new treatment modality in multiple sclerosis (MS)
    Novik, A. A.
    Afanasyev, B. V.
    Lisukov, I. A.
    Rykavicin, O. A.
    Ionova, T. I.
    Melnichenko, V. Y.
    Fedorenko, D. A.
    Kishtovich, A. V.
    Kruglina, R. V.
    Gorodokin, G. J.
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2008, 69 (03) : 145 - 145